Decibel Therapeutics Announces Submission of Clinical Trial Applications for Lead Gene Therapy Candidate DB-OTO

(marketscreener.com) BOSTON, Nov. 02, 2022 -- Decibel Therapeutics , a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced the submission of Clinical Trial Applications to the Medicines and Healthcare Products Regulatory Agency in the United Kingdom...https://www.marketscreener.com/quote/stock/DECIBEL-THERAPEUTICS-INC-118907233/news/Decibel-Therapeutics-Announces-Submission-of-Clinical-Trial-Applications-for-Lead-Gene-Therapy-Candi-42176389/?utm_medium=RSS&utm_content=20221102